{
    "Orphapacket": {
        "ORPHApacketId": "86846",
        "creationDate": "2022-11-28 11:04:13",
        "version": "1.3.18 / 4.1.7 [2022-07-12] (orientdb version)",
        "copyright": "Orphanet (c) 2022",
        "ORPHAcode": "86846",
        "Label": "Therapy related acute myeloid leukemia and myelodysplastic syndrome",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_86846",
        "DisorderType": {
            "value": "Category",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_557495"
        },
        "Synonyms": [
            {
                "Synonym": "Secondary AML"
            },
            {
                "Synonym": "Secondary acute myeloid leukemia"
            },
            {
                "Synonym": "Therapy-related AML and myelodysplastic syndrome"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "601626",
                "DisorderMappingRelation": "NTBT (ORPHA code's Narrower Term maps to a Broader Term)"
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "519",
                        "Label": "Acute myeloid leukemia"
                    }
                ]
            }
        ],
        "Childs": [
            {
                "Child": {
                    "Label": "Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent",
                    "ORPHAcode": "102379",
                    "Genes": "no data"
                }
            },
            {
                "Child": {
                    "Label": "Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor",
                    "ORPHAcode": "102381",
                    "Genes": "no data"
                }
            },
            {
                "Child": {
                    "Label": "Acute myeloid leukemia and myelodysplastic syndromes related to radiation",
                    "ORPHAcode": "164726",
                    "Genes": "no data"
                }
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "0.0",
                    "PrevalenceGeographic": "Europe"
                }
            ]
        },
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "All ages"
                }
            ]
        }
    }
}